UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Cancers, 2020-02, Vol.12 (3), p.546

2020

Volltextzugriff (PDF)

Targeting HER2 in Gastroesophageal Adenocarcinoma: Molecular Features and Updates in Clinical Practice

International journal of molecular sciences, 2024-04, Vol.25 (7), p.3876

2024

Volltextzugriff (PDF)

Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies

PloS one, 2018-07, Vol.13 (7), p.e0201425-e0201425

2018

Volltextzugriff (PDF)

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

Journal of translational medicine, 2011-10, Vol.9 (1), p.179-179, Article 179

2011

Volltextzugriff (PDF)

Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study

British journal of cancer, 2018-11, Vol.119 (11), p.1326-1331

2018

Volltextzugriff (PDF)

Clinical and Molecular Predictors of PD-L1 Expression in Non–Small-Cell Lung Cancer: Systematic Review and Meta-analysis

Clinical lung cancer, 2018-07, Vol.19 (4), p.315-322

2018

Volltextzugriff (PDF)

High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases

Frontiers in oncology, 2020-11, Vol.10, p.588862-588862

2020

Volltextzugriff (PDF)

Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres

Life (Basel, Switzerland), 2022-07, Vol.12 (8), p.1149

2022

Volltextzugriff (PDF)

MicroRNA and MET in lung cancer

Annals of translational medicine, 2015-04, Vol.3 (5), p.68-68

Brighenti, Matteo

2015

Volltextzugriff (PDF)

Gefitinib plus interleukin-2 in advanced non-small cell lung cancer patients previously treated with chemotherapy

Cancers, 2014-09, Vol.6 (4), p.2035-2048

2014

Volltextzugriff (PDF)

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014-10, Vol.17 (4), p.711-717

2014

Volltextzugriff (PDF)

Patient performance status and cancer immunotherapy efficacy: a meta-analysis

Medical oncology (Northwood, London, England), 2018-10, Vol.35 (10), p.132-12, Article 132

2018

Volltextzugriff (PDF)

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

The lancet oncology, 2020-07, Vol.21 (7), p.914-922

2020

Volltextzugriff (PDF)

Tocilizumab for COVID-19 Pneumonia in a Patient With Non–Small-cell Lung Cancer Treated With Chemoimmunotherapy

Clinical lung cancer, 2021-01, Vol.22 (1), p.e67-e69

2021

Volltextzugriff (PDF)

Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Journal of immunotherapy (1997), 2020-01, Vol.43 (1), p.1-7

2020

Volltextzugriff (PDF)

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Journal of clinical oncology, 2017-04, Vol.35 (12), p.1281-1287

2017

Volltextzugriff (PDF)

Is there still room for anti-angiogenic agents in small cell lung cancer?

Translational cancer research, 2018-04, Vol.7 (S4), p.S528-S529

2018

Volltextzugriff (PDF)

A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation–Positive NSCLC Patients

Journal of thoracic oncology, 2020-01, Vol.15 (1), p.80-90

2020

Volltextzugriff (PDF)

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed

European journal of cancer (1990), 2024-05, Vol.202, p.114006-114006, Article 114006

2024

Volltextzugriff (PDF)

Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?

European journal of cancer (1990), 2017-07, Vol.79, p.149-151

2017

Volltextzugriff (PDF)

A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale

Future oncology (London, England), 2022-03, Vol.18 (7), p.771-779

2022

Volltextzugriff (PDF)

Two sequential dose-dense regimens of CGP, followed by MVAC in patients with metastatic urothelial carcinoma (mUC): A single institution, explorative trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e16023-e16023

2019

Volltextzugriff (PDF)

High baseline lymphocyte count is a predictive biomarker of prolonged time to progression in patients with advanced solid tumors receiving checkpoint inhibitors

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e14532-e14532

2017

Volltextzugriff (PDF)

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

Lung cancer (Amsterdam, Netherlands), 2020-12, Vol.150, p.123-131

2020

Volltextzugriff (PDF)

Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14130-e14130

2019

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(72)
Tagungsberichte
(3)

Sprache

Englisch
(75)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(43)
Oncology
(30)
Humans
(28)
Male
(16)
Aged
(13)
Female
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Middle Aged
(11)
Technology
(11)
Adult
(9)
Disease-Free Survival
(8)
Immunotherapy
(8)
Lung Neoplasms - Drug Therapy
(8)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(7)
Lung Cancer
(7)
Physical Sciences
(7)
Treatment Outcome
(7)
Aged, 80 And Over
(6)
Chemotherapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Targeting HER2 in Gastroesophageal Adenocarcinoma: Molecular Features and Updates in Clinical Practice

Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study

Clinical and Molecular Predictors of PD-L1 Expression in Non–Small-Cell Lung Cancer: Systematic Review and Meta-analysis

High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases

Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres

MicroRNA and MET in lung cancer

Gefitinib plus interleukin-2 in advanced non-small cell lung cancer patients previously treated with chemotherapy

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

Patient performance status and cancer immunotherapy efficacy: a meta-analysis

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Tocilizumab for COVID-19 Pneumonia in a Patient With Non–Small-cell Lung Cancer Treated With Chemoimmunotherapy

Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Is there still room for anti-angiogenic agents in small cell lung cancer?

A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation–Positive NSCLC Patients

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed

Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?

A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale

Two sequential dose-dense regimens of CGP, followed by MVAC in patients with metastatic urothelial carcinoma (mUC): A single institution, explorative trial

High baseline lymphocyte count is a predictive biomarker of prolonged time to progression in patients with advanced solid tumors receiving checkpoint inhibitors

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis

Suchergebnisse filtern